TY - JOUR
T1 - HLA-class i markers and multiple sclerosis susceptibility in the Italian population
AU - Bergamaschi, L.
AU - Leone, M. A.
AU - Fasano, M. E.
AU - Guerini, F. R.
AU - Ferrante, D.
AU - Bolognesi, E.
AU - Barizzone, N.
AU - Corrado, L.
AU - Naldi, P.
AU - Agliardi, C.
AU - Dametto, E.
AU - Salvetti, M.
AU - Visconti, A.
AU - Galimberti, D.
AU - Scarpini, E.
AU - Vercellino, M.
AU - Bergamaschi, R.
AU - Monaco, F.
AU - Caputo, D.
AU - Momigliano-Richiardi, P.
AU - D'Alfonso, S.
N1 - Funding Information:
This work was supported by the Italian Foundation for Multiple Sclerosis (FISM grants 2001/R/44, 2002/R/40 and 2005/R/10, 2008/R/11); CARIPLO Foundation, Regione Piemonte Ricerca Sanitaria Finalizzata (grants 2003, 2004, 2007, 2008), Regione Piemonte CIPE 2004, Ministry of Health (ricerca finalizzata grant 2004.80), Eastern Piedmont University (grants to SD and PMR). Compagnia di San Paolo (Turin), Fondazione CRT (Turin). DG and ES were supported by Fondazione Monzino, Ospedale Maggiore Policlinico and Ing. Cesare Cusan. NB was supported by a fellowship from FISM (2003/B/2). LB is a ‘Biotechnology for Health’ PhD student supported by a PhD Lagrange Fellowship. We are grateful to the patients and their parents and also to Professor Corrado Magnani for helpful discussion and to Dr Roberto Tosi for critical suggestions.
PY - 2010/3
Y1 - 2010/3
N2 - Previous studies reported an association with multiple sclerosis (MS) of distinct HLA-class I markers, namely HLA-A02, HLA-Cw05 and MOG-142L. In this work, we tested the association with MS of A02 and Cw05 in 1273 Italian MS patients and 1075 matched controls, which were previously analyzed for MOG-142, and explored the relationship among these three markers in modulating MS risk. HLA-A02 conferred a statistically robust MS protection (odds ratio, OR0.61; 95% confidence intervals, CI0.51-0.72, P10 9), which was independent of DRB115 and of any other DRB1 allele and remained similar after accounting for the other two analyzed class I markers. Conversely, the protective effect we previously observed for MOG-142L was secondary to its linkage disequilibrium with A02. Cw05 was not associated considering the whole sample, but its presence significantly enhanced the protection in the HLA-A02-positive group, independently of DRB1: the OR conferred by A02 in Cw05-positive individuals (0.22, 95% CI0.13-0.38) was significantly lower than in Cw05-negative individuals (0.69, 95% CI0.58-0.83) with a significant (P4.94 × 10 5) multiplicative interaction between the two markers. In the absence of A02, Cw05 behaved as a risk factor, particularly in combination with DRB103 (OR3.89, P0.0006), indicating that Cw05 might be a marker of protective or risk haplotypes, respectively.
AB - Previous studies reported an association with multiple sclerosis (MS) of distinct HLA-class I markers, namely HLA-A02, HLA-Cw05 and MOG-142L. In this work, we tested the association with MS of A02 and Cw05 in 1273 Italian MS patients and 1075 matched controls, which were previously analyzed for MOG-142, and explored the relationship among these three markers in modulating MS risk. HLA-A02 conferred a statistically robust MS protection (odds ratio, OR0.61; 95% confidence intervals, CI0.51-0.72, P10 9), which was independent of DRB115 and of any other DRB1 allele and remained similar after accounting for the other two analyzed class I markers. Conversely, the protective effect we previously observed for MOG-142L was secondary to its linkage disequilibrium with A02. Cw05 was not associated considering the whole sample, but its presence significantly enhanced the protection in the HLA-A02-positive group, independently of DRB1: the OR conferred by A02 in Cw05-positive individuals (0.22, 95% CI0.13-0.38) was significantly lower than in Cw05-negative individuals (0.69, 95% CI0.58-0.83) with a significant (P4.94 × 10 5) multiplicative interaction between the two markers. In the absence of A02, Cw05 behaved as a risk factor, particularly in combination with DRB103 (OR3.89, P0.0006), indicating that Cw05 might be a marker of protective or risk haplotypes, respectively.
KW - Extended HLA haplotypes
KW - Genetic association
KW - HLA-class I markers
KW - Multiple sclerosis
KW - Myelin Oligodendrocyte Glycoprotein
UR - http://www.scopus.com/inward/record.url?scp=77649342927&partnerID=8YFLogxK
U2 - 10.1038/gene.2009.101
DO - 10.1038/gene.2009.101
M3 - Article
SN - 1466-4879
VL - 11
SP - 173
EP - 180
JO - Genes and Immunity
JF - Genes and Immunity
IS - 2
ER -